That there is only a couple of millions being invested each year,
You draw that inference from? How do you calculate only a couple of million?
That there is only a couple of millions being invested each year,
I believe Profesor Tzounopoulos at the University of Pittsburgh is working on some kind of potassium channel opener drug like Trobalt, too, backed by a big pharma, though it's almost been a year since last news. Maybe someone can email him?The best option for a "new trobalt" is 1OP-2198 right ?
Yes but it's being developed for epilepsy, more potent with fewer side effects (hopefully won't turn you blue and give you milky man tits).
If it's going to be for T it would be off label use.
This is great they are actually on time with the recruitment dates. First patient was enrolled on 30/05.
Hopefully everything will go well
It's not likely to tell much IMO as the time between the injection and the surgery can go from 0 h to 24 h. It's likely the effect of the drug won't even seen in that little amount of time.The assessment of tinnitus outcome is in their second objective to see if it makes it better or worse. Time will soon tell.
Yes but it's being developed for epilepsy, more potent with fewer side effects (hopefully won't turn you blue and give you milky man tits).
I may have asked this question before, but a theory of tinnitus persistence is that the signal are boosted in the dorsal cochlear nucleous (something like that) during a hearing threshold shift. When the hearing returns back to normal, tinnitus (or the DCN boosting its signals) remains a memory.
How would hearing cell regeneration fix that memory to alleviate tinnitus? This may explain why tinnitus does not always accompany hearing loss?
I believe Profesor Tzounopoulos at the University of Pittsburgh is working on some kind of potassium channel opener drug like Trobalt, too, backed by a big pharma, though it's almost been a year since last news. Maybe someone can email him?
By the way, 1OP-2198 is now called XEN1101. Phase 1 is expected to start later this year with a phase 2 rolling out in mid 2018. Since Trobalt works/worked for many of us, me included, I'd definitely keep track of this new version.
The preliminary data I have seen in animal models look promising.
As they're testing for epilepsy, what makes you think it looks promising for tinnitus?
You mean prof. Tzounopoulos' work, don't you?He is working with physical chemists and industry partners to develop a targeted, better tolerated compound that will act on the KCNQ2/3 variant of the voltage-gated potassium channel. The preliminary data I have seen in animal models look promising.
I thought tinnitus was their main (and only) target. At least that was what we were told in their last press release. Have they changed their focus?If it comes from the Tzounopoulos lab, it is very high quality work and you can be sure they are thinking about possible applications to tinnitus.
You mean prof. Tzounopoulos' work, don't you?
I thought tinnitus was their main (and only) target. At least that was what we were told in their last press release. Have they changed their focus?
Thanks @HomeoHebbian for your detailed response. Drugs usually take a very long time to come market, if they are successful. Are we in fact looking at a seven to ten year time frame for something like this to become available to the general public?
I also don't know how inner ear hair cell regeneration is done. Is it anything like 3D printing?
Isn't Allergan backing the research as stated in the pr?Yes, you are absolutely right about that. My recollection from seeing a talk a few months ago was that the pre-clinical data were strong enough to warrant a healthy dose of funding from a big Pharma partner for Phase 1. I'll ask around and if I learn anything useful will report back...
@Roger_S This thread is shorter and should answer some of your questions. https://www.tinnitustalk.com/threads/frequency-therapeutics-—-hearing-loss-regeneration.18889/This seems like the most interesting thread about curing tinnitus.
Is there any thread as hopeful as this one?
Can someone start a new thread #2 with the same topic summarizing what has been going on so far? I'm reading about starting a Phase I on page 2-5. I still get tired quickly and I think I'm not the only one.
Even if they aren't, I think you and I would be happy to have it 90% back to the way it was.Maybe. But I am concerned that there is no way the newly formed connections will be the same or perform the same as the original ones and that it may not stop the tinnitus.
Its obviously far less than a billion $ each year. I guess here on this forum we know about 90% of all projects. Even the most expensive ones, like am101 costs just a medium 2digit M$ amount even during their costly trial phase.You draw that inference from? How do you calculate only a couple of million
So a couple of million was an incorrect summary of the monies involved?Its obviously far less than a billion $ each year. I guess here on this forum we know about 90% of all projects. Even the most expensive ones, like am101 costs just a medium 2digit M$ amount even during their costly trial phase.
So in poker it would be called a blind what is invested right now.
Just compare the numbers, consider the VW diesel scandal and how much money is paid for this health issue. Ridicilous!